Advantages of Dexmedetomidine in Traumatic Brain Injury - a Review. | [Anaesthesia, Pain and Intensive Care • 2015]

Author(s):

1. Subodh Kamtikar: Department of Anesthesiology, Bidar Institute of Medical Sciences, Karnataka State, India

2. Abhijit S Nair: Department of Anesthesiology & Critical Care, Citizens Hospital, Hyderabad, India

Abstract:

Patients with traumatic brain injury (TBI) require mechanical ventilation for airway protection, to reduce work of breathing, to reduce cerebral metabolic rate and to optimize intracerebral hemodynamics. Drugs like narcotics, benzodiazepines, propofol and alpha-2 agonists with or without non-depolarizing muscle relaxants are used to facilitate mechanical ventilation. We reviewed literature on search engines PubMed and Medline to determine the efficacy and feasibility of dexmedetomidine as the sole sedative agent in patients with TBI in terms of maintenance of hemodynamics, ease of neurological assessment with ongoing sedation and long term neurological outcome.

Page(s): 87-91

DOI: DOI not available

Published: Journal: Anaesthesia, Pain and Intensive Care, Volume: 19, Issue: 1, Year: 2015

Keywords:

Keywords are not available for this article.

References:

[1] BhanaN,GoaKL,McClellanKJ,GertlerR,BrownHC,MitchellDH,SilviusEN, 2001.Dexmedetomidine: a novel sedative analgesic agent,Proc (Bayl Univ Med Cent) 14 13 -21

[2] 2008.Dexmedetomidine: sedation, analgesia and beyond,Expert Opin Drug Metab Toxicol 4 619 -

[3] RobertsDJ,HallRI,KramerAH,RobertsonHL,GallagherCN,ZygunDA,UrwinSC,MenonDK, 2004.Comparative tolerability of sedative agents in headinjured adults,Drug Saf 27 107 -33

[4] AdembriC,VenturiL,PellegriniGiampietro DE, 2007.Neuroprotective effects of propofol in acute cerebral injury,CNS Drug Rev 13 333 -51

[5] KotaniY,ShimazawaM,YoshimuraS,IwamaT,HaraH., 2008.The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties,CNS Neurosci Ther 00043 95 -3458

[6] JohnstonAJ,SteinerLA,ChatfieldDA,ColemanMR,ColesJP,AlRawiPG, 2003.Effects of propofol on cerebral oxygenation and metabolism after head injury,Br J Anaesth 91 781 -

[7] TanguyM,SeguinP,LaviolleB,BleichnerJP,MorandiX,MalledantY., 1817.Cerebral microdialysis effects of propofol versus midazolam in severe traumatic brain injury,2012 Apr 10 1105 -10

[8] GhoriKA,HarmonDC,ElashaalA,ButlerM,WalshF,O'SullivanMG, 2007.Effect of midazolam versus propofol sedation on markers of neurological injury and outcome after isolated severe head injury: a pilot study,Crit Care Resusc 9 166 -

[9] KamPC,CardoneD., 2007.Propofol infusion syndrome,Anaesthesia 62 690 -701

[10] SabsovichI,RehmanZ,YunenJ,CoritsidisG, 2007.Propofol infusion syndrome: a case of increasing morbidity with traumatic brain injury,Am J Crit Care 16 82 -

[11] FodaleV,La, 2008.Propofol infusion syndrome: an overview of a perplexing disease,Drug Saf 31 293 -

[12] CannonML,GlazierSS,BaumanLA, 2001.Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion,J Neurosurg 95 1053 -

[13] FudickarA,BeinB, 2009.Propofol infusion syndrome: update of clinical manifestation and pathophysiology,Minerva Anestesiol 75 339 -

[14] SchifillitiD,GrassoG,ContiA,FodaleV, 2010.Anaesthetic related neuroprotection: intravenous or inhalational agents?,CNS Drugs 24 11584760 -907

[15] HeadBP,PatelP, 2007.Anesthetics and brain protection,Curr Opin Anaesthesiol 20 3959 -

[16] KoernerIP,BrambrinkAM, .Brain protection by anesthetic agents,Curr Opin -

[17] Anaesthesiol, 2006., 19 481 -

[18] StatlerKD,AlexanderH,VagniV,DixonCE,ClarkRS,JenkinsL, 2006.Comparison of seven anesthetic agents on outcome after experimental traumatic brain injury in adult, male rats,J Neurotrauma 23 97 -

[19] TawfeeqNA,HalawaniMM,AlFaridiK,AalShayaWA,TahaWS, 2009.Traumatic brain injury: neuroprotective anaesthetic techniques, an update,2009 Nov;40 Suppl 10 S75 -81

[20] FlowerO,HellingsS., 2012.Sedation in traumatic brain injury,Emerg Med Int 637171 -

[21] FlynnG,ShehabiY, 2012.Is etomidate safe in hemodynamically unstable critically ill patients? Crit Care, 16 227 -

[22] ChangLC,RatySR,OrtizJ,BailardNS,MathewSJ, 2013.The emerging use of ketamine for anesthesia and sedation in traumatic brain injuries,CNS Neurosci Ther 19 390 -

[23] RhoneyDH,ParkerD,Jr, 2001.Use of sedative and analgesic agents in neurotrauma patients: effects on cerebral physiology,Neurol Res 23 237 -

[24] RobertsI,SydenhamE, pub2.Barbiturates for acute traumatic brain injury,Cochrane Database Syst Rev 2012 Dec 12 CD000033 -

[25] TangJF,ChenPL,TangEJ,MayTA,StiverSI, 2011.Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a nonintubated patient with traumatic brain injury,Neurocrit Care 15 175 -

[26] HaoJ,LuoJS,WengQ,HeY,LiuJ,YangMH, 2013.Effects of dexmedetomidine on sedation and βendorphin in traumatic brain injury: a comparative study with propofol,Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 06 4352 -6

[27] JamesML,OlsonDM,Graffagnino C, 2012.A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury,Anaesth Intensive Care 40 57 -

[28] SchoelerM,LoetscherPD,RossaintR,FahlenkampAV,EberhardtG,RexS,WeisJ,CoburnM., 2012.Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury,BMC Neurol 12 1471 -

[29] NakanoT,OkamotoH, 2009.Dexmedetomidineinduced cerebral hypoperfusion exacerbates ischemic brain injury in rats,J Anesth 23 378 -

[30] BenggonM,ChenH,ApplegateR,MartinR,ZhangJH, 2012.Effect of dexmedetomidine on brain edema and neurological outcomes in surgical brain injury in rats,Anesth Analg 115 154 -

[31] FaragE,ArgaliousM,SesslerDI,KurzA,EbrahimZY,SchubertA, 2011.Use of αAgonists in Neuroanesthesia: An Overview, 11 57 -69

[32] AryanHE,BoxKW,IbrahimD,DesirajuU,AmesCP, 2006.Safety and efficacy of dexmedetomidine in neurosurgical patients,Brain Inj 20 791 -

[33] RozetI., 2008.Anesthesia for functional neurosurgery: the role of dexmedetomidine,Curr Opin Anaesthesiol 21 537 -

[34] 2005.Dexmedetomidine for neurological surgery,Neurosurgery 57 1 -10

[35] MaD,HossainM,RajakumaraswamyN,ArshadM,SandersRD,FranksNP, 2004.Dexmedetomidine produces its neuroprotective effect via the alpha 2Aadrenoceptor subtype,Eur J Pharmacol 502 97 -

[36] GuinterJR,KristellerJL, 2010.Prolonged infusions of dexmedetomidine in critically ill patients,Am J Health Syst Pharm 67 1246 -

[37] KunisawaT., .Dexmedetomidine hydrochloride as a longterm sedative,Ther -

[38] 2011.,Clin Risk Manag 7 291 -299

[39] TobiasJD, .Dexmedetomidine: Are There Going to be Issues with Prolonged, -

[40] Administration? J Pediatr Pharmacol Ther, 2010., 15 4 -9

Citations

Citations are not available for this document.

Citations

Downloads

Views